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Abstract
In this commentary on the exercise of Lehoux et al (this volume) I argue that in discussions on the current 
challenges of health systems, a better diagnosis of the health system is required. The cause of responsible 
innovation in health (RIH) requires a better understanding of the dynamics of health systems, in particular how 
innovation, demand, and responsibility are manifested. Innovation brings its own dynamic to the health system; 
demands are linked to historical and social developments; responsibility brings contestations about what counts 
as good healthcare. Any attempt of RIH should include such reflections.
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Everywhere in healthcare, questions of future directions are prominent. A key question is what today’s urgent healthcare problems are and how they should be 
addressed by health systems – a question that is addressed 
by Pascal Lehoux and colleagues (this volume).1 In their 
paper, they map the current challenges of health systems 
through an extensive global literature review; they also argue 
that addressing these challenges should be on the agenda 
of responsible innovation in health (RIH). Their exercise is 
rigorous, timely and a valuable landmark for health policy. 
The appeal to guide the health system towards more 
responsibility and sustainability is appropriate, yet seems to 
ignore some pertinent questions about what health systems 
are and do. The assumption seems to be that once priorities are 
known, policy-makers are able to guide the health systems into 
the desired direction. Of course, no one will deny that other 
factors play a role as well, sometimes referred to as ‘politics’ or 
‘opposition.’ It is helpful, however, to pay some more careful 
attention to these other factors. In fact, the exercise of Lehoux 
and colleagues itself points to some fundamental issues about 
the dynamics of health systems. A good starting point is their 
observation at the beginning of their Concluding Remarks 
section: “Since the late 1980s, new health technologies not 
only increased global inequalities, but they also undermined 
the sustainability of health systems in rich and poor countries 
alike.” In other words, more investments, intensified efforts and 
better technologies do not just bring progress, they may also 
bring detrimental consequences. This dramatic observation is 
countered by Lehoux et al by the urge to do better: “It will be 
imperative to implement policy mechanisms that can support 
the development, financing and use of innovations that do 
not compromise but rather contribute to the success and 
sustainability of health systems.” I would argue that this urge 
to do better is not sufficient: we also need a better diagnosis 
of why health systems may not deliver their promises. In this 
commentary, I will address some fundamental issues about 
the dynamics of health systems, in particular in relation to the 
key notions in the paper of Lehoux et al: innovation, demand, 
and responsibility.
Innovation
In health systems, technologies obviously play a central role 
and using and improving them (innovation) often makes 
sense. Due to new technologies, health systems are better 
able to monitor patients, deliver drugs and facilitate care. 
Yet, as a rule, technologies are not simply clever answers to 
good questions; they bring about novel dynamics, too. I will 
support my argument with the example of the introduction of 
the Da Vinci robot in surgery in the Netherlands, studied by 
Abrishami and colleagues.2 Their study shows that decisions 
to install a very expensive Da Vinci surgical robot have not 
been the result of clear cost-benefit calculations, or by health 
technology assessment reports, but are the outcomes of 
complex interactions and interdependencies. Hospitals, for 
instance, see the purchase of a Da Vinci surgical robot as a 
move in their ongoing competition for status, reputation and 
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visibility with other hospitals. Patients, in their turn, want the 
best treatment possible and take ‘novel’ as an indication with 
‘better,’ hence express a favour for robotized surgery. Policy-
makers, on the other hand, follow the choice of patients, 
believing that ‘the market’ will reduce costs and increased 
efficiency. Surgeons seek to reaffirm their pivotal role in 
health systems, while elder surgeons who suffer a bit more 
from trembling than in their younger days favour the surgical 
robot to hide their declining skills. The innovation of the 
surgical robot, thus, brings much more to the table than just 
technical gains – something to be taken on board by policy-
makers. 
Demand
A second fundamental issue concerns the idea of demand. 
The mapping of demands that Lehoux et al perform is 
based on the assumption that this is a useful starting point 
for innovation – a contested assumption. Some decades ago, 
the discussion about the drivers of innovation was phrased 
in terms of ‘demand pull’ versus ‘technology push’: does the 
origin of novelty reside in what people need, with innovation 
as a response, or does it start with new technologies inciting 
use and further adoption? The consensus in innovation 
studies now is that both mechanisms are at work, but that the 
dichotomy is misleading, too, as both extremes presume a 
linearity in the development from invention on the one hand, 
to usage at the other. Many studies have shown that inventions 
are shaped by interests and imaginations, while usage includes 
more than a passive uptake.3 Users are innovators in their own 
right. 
What is more, demand in health systems is never just a 
simple expression of what is needed, but also an expression of 
what can be rightfully asked for. Demand, thus, also expresses 
competition, imitation and cultural shifts in what counts as 
‘healthy’ and ‘justified.’ For example, in many countries in 
vitro fertilization is now seen as a proper response to a rightful 
demand; this was certainly not the case several decades ago, 
when the mere possibility of in vitro fertilization entered the 
world.4 At that time it was seen as unnatural and beyond the 
tasks of health systems. 
My point is not to be cynical or relativistic about demands 
in health systems – the suffering is real and the need to 
respond is urgent – but to fully acknowledge that demand is 
not ‘just there,’ waiting to be mapped. Demand is always an 
outcome of societal developments with a history, a context 
with winners and losers; it is a summary of ideas about what 
needs to be repaired, about possibilities to do so and about 
the justification to perform. In this way, also the issue of 
rising costs of healthcare due to rising demand should also 
be interpreted differently. Instead of understanding the rise 
of healthcare costs as a burden to be alleviated with austerity, 
one could also interpret the rising costs as an indication of 
changing possibilities and priorities: apparently, a society is 
able and willing to spend more on healthcare. 
Responsibility
Lehoux et al see RIH as an endeavour to guide health systems 
towards what is ‘affordable,’ ‘acceptable,’ and ‘adaptable.’ Their 
characterization of responsibility resonates with the rise of 
responsible innovation in research agendas at large, such as 
those in European Horizon 2020 programmes. It also reflects 
a broader tendency in science, technology and health policies 
to guide innovations towards societal needs. Clearly, the 
notion of responsibility comes with high hopes that it will give 
directions for further (health) research. Yet, these directions 
will not come from formulating the right principles alone – 
it will also necessarily involve negotiation, articulation, and 
contestation. 
A strong example of such struggles around ‘responsible’ 
healthcare is the case of early diagnostics for Alzheimer’s 
disease.5 Clearly, Alzheimer’s disease is one of the major 
global challenges, in particular in higher income countries. 
As a response, medical researchers make huge efforts to study 
the disease and receive large funds to diagnose it earlier, in the 
hope to unravel the pathways of the disease. These research 
directions can be questioned in many ways. For instance, 
what is being diagnosed in the first place? The more research 
publications on the condition appear, the more the notion 
of Alzheimer’s disease itself becomes elusive. The clinical 
indications vary enormously and follow many tracks such 
as the significance of amyloid proteins in the brain, or the 
consequences of ‘tangles.’ The scientific disputes even extend 
to the question whether it should be counted as a disease at all, 
or, as some geriatrists argue, as a ‘natural’ aging of the body 
and the brain. Another critique on the massive investments 
into research and the concomitant hopes of cure is that these 
go at the expense of other forms of care.6 Many argue that 
there are better ways to take care of the millions of patients 
and caretakers that currently suffer from the disease. Some 
even argue that it is not ethical to launch promises about an 
eventual cure. Typically, medical research funding comes with 
a discourse of hope and fear, so-called regimes of hope, which 
may indeed lead to funding but will also feed concerns and 
existential fears.7 
What the example makes clear is that when considering 
responsible innovations in health systems, more is at stake 
than a decision to fund or not to fund. Is it justified, for 
instance, to focus on early diagnosis, in particular when a cure 
is not in sight, or is it more responsible to invest in better forms 
of care? What are the consequences of launching promises of 
early diagnosis and of a possible cure in the distant future? 
Such questions require negotiation, articulation and any 
answer can be contested, in principle and in practice. 
The three fundamental questions about innovation, 
demand, and responsibility show that a health system is 
more than a collection of care practices supported with 
technologies. It entails also collective hopes of what can be 
achieved, historically informed imaginations of what is 
healthy and justified and contested ideas of what is responsible. 
Any attempt for a responsible health system, thus, implies a 
further diagnosis of how health systems work and a collective 
reflection on what directions are desirable and responsible.
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